Bank of New York Mellon’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.5M | Buy |
|
|||||
|
2025
Q2 | $38M | Sell |
|
|||||
|
2025
Q1 | $40.7M | Buy |
|
|||||
|
2024
Q4 | $32.9M | Buy |
|
|||||
|
2024
Q3 | $39M | Buy |
|
|||||
|
2024
Q2 | $35.7M | Buy |
|
|||||
|
2024
Q1 | $36.7M | Sell |
|
|||||
|
2023
Q4 | $33.2M | Sell |
|
|||||
|
2023
Q3 | $34M | Sell |
|
|||||
|
2023
Q2 | $33.9M | Sell |
|
|||||
|
2023
Q1 | $35.5M | Sell |
|
|||||
|
2022
Q4 | $36.4M | Buy |
|
|||||
|
2022
Q3 | $30.4M | Buy |
|
|||||
|
2022
Q2 | $51.3M | Buy |
|
|||||
|
2022
Q1 | $50.6M | Sell |
|
|||||
|
2021
Q4 | $56M | Sell |
|
|||||
|
2021
Q3 | $58.3M | Buy |
|
|||||
|
2021
Q2 | $48.1M | Sell |
|
|||||
|
2021
Q1 | $43.9M | Sell |
|
|||||
|
2020
Q4 | $47.6M | Sell |
|
|||||
|
2020
Q3 | $55.4M | Sell |
|
|||||
|
2020
Q2 | $62.1M | Sell |
|
|||||
|
2020
Q1 | $66.7M | Sell |
|
|||||
|
2019
Q4 | $101M | Buy |
|
|||||
|
2019
Q3 | $91.2M | Buy |
|
|||||
|
2019
Q2 | $84.2M | Sell |
|
|||||
|
2019
Q1 | $90.8M | Sell |
|
|||||
|
2018
Q4 | $87.2M | Sell |
|
|||||
|
2018
Q3 | $92.6M | Sell |
|
|||||
|
2018
Q2 | $246M | Buy |
|
|||||
|
2018
Q1 | $223M | Sell |
|
|||||
|
2017
Q4 | $204M | Sell |
|
|||||
|
2017
Q3 | $237M | Sell |
|
|||||
|
2017
Q2 | $253M | Sell |
|
|||||
|
2017
Q1 | $249M | Sell |
|
|||||
|
2016
Q4 | $231M | Sell |
|
|||||
|
2016
Q3 | $261M | Buy |
|
|||||
|
2016
Q2 | $259M | Buy |
|
|||||
|
2016
Q1 | $241M | Sell |
|
|||||
|
2015
Q4 | $248M | Sell |
|
|||||
|
2015
Q3 | $240M | Buy |
|
|||||
|
2015
Q2 | $258M | Sell |
|
|||||
|
2015
Q1 | $288M | Sell |
|
|||||
|
2014
Q4 | $268M | Sell |
|
|||||
|
2014
Q3 | $294M | Sell |
|
|||||
|
2014
Q2 | $356M | Sell |
|
|||||
|
2014
Q1 | $364M | Sell |
|
|||||
|
2013
Q4 | $366M | Sell |
|
|||||
|
2013
Q3 | $422M | Sell |
|
|||||
|
2013
Q2 | $458M | Buy |
|